Rebecca Karsenti, MD
Obstetrics & Gynecology · Miami, FLNPI 1992907117
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,776 of the $3,089 with a category attached, or 89.8%. It is spread thinly across 34 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.
Across 143 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$446
- AbbVie$388
- Mayne Pharma Commercial LLC$180
- Pfizer$170
- Hologic Sales And Service, LLC$159
- Millicent US Inc$149
- plus $2K from 28 others
What the payments were for
- Food & beverage$2,77690%
- Education$31410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 12 | $446 |
| AbbVie(2 entities) | 22 | $388 |
| Mayne Pharma Commercial LLC | 6 | $180 |
| Pfizer | 7 | $170 |
| Hologic Sales And Service, LLC | 6 | $159 |
| Millicent US Inc | 8 | $149 |
| Biogen | 7 | $148 |
| Sumitomo Pharma America, Inc. | 6 | $138 |
| Therapeuticsmd, Inc. | 7 | $135 |
| Coopersurgical, Inc. | 8 | $133 |
| Myovant Sciences Inc. | 8 | $120 |
| Evofem Biosciences, Inc. | 6 | $117 |
| Medicem Inc. | 1 | $99 |
| Exact Sciences | 4 | $87 |
| Mission Pharmacal Company | 5 | $83 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Avion Pharmaceuticals | 3 | $45 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Exeltis, USA Inc. | 2 | $44 |
| Scynexis, Inc. | 2 | $37 |
| Lupin Inc. | 2 | $31 |
| Duchesnay USA Incorporated | 2 | $28 |
| Organon | 3 | $23 |
| Amgen | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Innovation Technologies Inc | 1 | $22 |
| Meditrina | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Merck | 1 | $21 |
| Gynesonics, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Bayer | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
How this compares
$3,089 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.